Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
16 hedge funds and large institutions have $306K invested in Novo Integrated Sciences, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.06% less ownership
Funds ownership: 5.78% → 5.72% (-0.06%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
63% less capital invested
Capital invested by funds: $826K → $306K (-$520K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$43.7K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$9.96K |
| 3 |
Goldman Sachs
New York
|
+$8.91K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.26K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$881 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$30.9K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$21.3K |
| 3 |
VF
Virtu Financial
New York
|
-$16.8K |
| 4 |
Millennium Management
New York
|
-$8.64K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$3.41K |
NVOS Hedge Fund Activity: Q3 2024 in Review
16 of the 6,980 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q3 2024, worth a combined $306K — down 63% from $826K a quarter earlier.
Fund positioning in NVOS was balanced in Q3 2024: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 5 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $43.7K. The largest seller was Jane Street, cutting an estimated $30.9K.
- 16 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $306K of Novo Integrated Sciences, Inc. Common Stock stock for Q3 2024, down 63% quarter-over-quarter.
- 3 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q3 2024 and 3 closed out, a net change of 0 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q3 2024 was HRT Financial, an estimated $43.7K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q3 2024 was Jane Street, an estimated $30.9K sold.
Based on aggregated 13F filings for Q3 2024.